MDS Proteomics Names New CFO, Eyes IPO in 02

Dec 11, 2001

NEW YORK, Dec. 11 - MDS Proteomics on Tuesday has named Anil K. Amlani to be its chief financial officer.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.